Recent Trends in The Diagnosis and Pharmacotherapy of Stroke

Stroke is a leading cause of morbidity and mortality worldwide, necessitating timely and effective diagnosis and treatment. Recent advancements in imaging technologies, novel thrombolytic agents, and emerging nanotechnologies have transformed the landscape of stroke care. This comprehensive review aims to provide an overview of the current state-of-the-art techniques for stroke diagnosis and treatment. We discuss the role of diffusion-weighted MRI, novel thrombolytic agents, anticoagulation therapy, and emerging nanotechnologies in improving patient outcomes. Our findings highlight the need for a multidisciplinary approach to optimize stroke care, incorporating cutting-edge imaging technologies, effective thrombolytic agents, and innovative nanotechnologies. This review provides a valuable resource for clinicians, researchers, and healthcare professionals seeking to stay up-to-date with the latest advancements in stroke diagnosis and treatment, ultimately aiming to improve patient outcomes and reduce the global burden of stroke.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-03-07
DOI
https://doi.org/10.5281/zenodo.14989606
Primary Topic
Acute Ischemic Stroke Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Recent Trends in The Diagnosis and Pharmacotherapy of Stroke

Zenodo (CERN European Organization for Nuclear Research)
Acute Ischemic Stroke Management
article

Recent Trends in The Diagnosis and Pharmacotherapy of Stroke

article en

Abstract

Stroke is a leading cause of morbidity and mortality worldwide, necessitating timely and effective diagnosis and treatment. Recent advancements in imaging technologies, novel thrombolytic agents, and emerging nanotechnologies have transformed the landscape of stroke care. This comprehensive review aims to provide an overview of the current state-of-the-art techniques for stroke diagnosis and treatment. We discuss the role of diffusion-weighted MRI, novel thrombolytic agents, anticoagulation therapy, and emerging nanotechnologies in improving patient outcomes. Our findings highlight the need for a multidisciplinary approach to optimize stroke care, incorporating cutting-edge imaging technologies, effective thrombolytic agents, and innovative nanotechnologies. This review provides a valuable resource for clinicians, researchers, and healthcare professionals seeking to stay up-to-date with the latest advancements in stroke diagnosis and treatment, ultimately aiming to improve patient outcomes and reduce the global burden of stroke.

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 46%
Acute Ischemic Stroke Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Recent Trends in The Diagnosis and Pharmacotherapy of Stroke · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS